首页> 美国卫生研究院文献>Infection and Immunity >Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.
【2h】

Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.

机译:6-O-酰基-muramyldipepteptides的辅助活性以增强豚鼠的主要细胞和体液免疫反应:选择化合物观察到的剂量反应和局部反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

6-O-(2-Tetradecylhexadecanoyl)-N-acetylmuramyl-L-alanyl-D-isoglutamine (B3O-MDP) and 6-O-(3-hydroxy-2-docosylhexacosanoyl)-MDP (BH48-MDP) were examined for immunopotentiating activity in stimulating the primary immune responses of guinea pigs to ovalbumin and for adverse reactions at the injection site and in the regional lymph nodes when administered in combination with several nonirritating vehicles. B30-MDP was found to potently stimulate both humoral and cellular immune responses, the latter by induction of delayed-type hypersensitivity, irrespective of the administration vehicle examined (liposomes, a squalene in water emulsion, Intralipid, phosphate-buffered saline, and Nikkol HCO-60 glucose solution), although the minimum effective dose was dependent on the vehicle used. Reactions in the footpad receiving the injection were negligible. Noticeable local reaction consisted of swelling of the lymph nodes in the region of the injection, but the swelling was only noted with higher doses and subsided 3 to 4 weeks after immunization, unlike the persistent swelling caused by the administration of water-in-mineral oil emulsions with or without B30-MDP. BH48-MDP and its L-serine analog, BH48-MDP(L-Ser), which has L-serine in place of L-alanine in MDP, in combination with the squalene-in-water emulsion, also intensely stimulated both cellular and humoral antiovalbumin immune responses, but the effects of these compounds seemed to be influenced to a greater degree by the vehicles than by B30-MDP. Thus, B30-MDP was chosen from a series of a 6-O-acyl derivatives of MDP as the most promising candidate for possible application in practical vaccines.
机译:检查了6-O-(2-十四烷基十六烷酰基)-N-乙酰基村酰基-L-丙氨酰基-D-异谷氨酰胺(B3O-MDP)和6-O-(3-羟基-2-二十二烷基六二十烷酰基)-MDP(BH48-MDP)的与几种无刺激性的载体联合使用时,增强免疫力的活性可刺激豚鼠对卵白蛋白的主要免疫反应以及注射部位和区域淋巴结的不良反应。发现B30-MDP可以有效地刺激体液和细胞免疫反应,后者通过诱导迟发型超敏反应而引起,而与所检查的给药载体无关(脂质体,角鲨烯水乳液,脂质体内,磷酸盐缓冲盐水和Nikkol HCO -60葡萄糖溶液),尽管最小有效剂量取决于所用的载体。接受注射的脚垫中的反应可以忽略不计。明显的局部反应包括注射部位的淋巴结肿胀,但肿胀仅在较高剂量时才注意到,并且在免疫后3至4周消退,这与矿泉水给药引起的持续肿胀不同有或没有B30-MDP的乳液。 BH48-MDP及其L-丝氨酸类似物BH48-MDP(L-Ser)在MDP中具有L-丝氨酸代替L-丙氨酸,并与角鲨烯水乳液一起强烈刺激细胞和细胞。体液中的抗卵清蛋白免疫反应,但这些载体的作用似乎受到媒介的影响比受B30-MDP的影响更大。因此,B30-MDP选自一系列MDP的6-O-酰基衍生物,作为在实际疫苗中可能应用的最有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号